AU2001261416A1 - Compounds and methods for the diagnosis and treatment of babesia microti infection - Google Patents

Compounds and methods for the diagnosis and treatment of babesia microti infection

Info

Publication number
AU2001261416A1
AU2001261416A1 AU2001261416A AU6141601A AU2001261416A1 AU 2001261416 A1 AU2001261416 A1 AU 2001261416A1 AU 2001261416 A AU2001261416 A AU 2001261416A AU 6141601 A AU6141601 A AU 6141601A AU 2001261416 A1 AU2001261416 A1 AU 2001261416A1
Authority
AU
Australia
Prior art keywords
diagnosis
compounds
treatment
methods
babesia microti
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001261416A
Inventor
Mary J. Homer
Raymond L. Houghton
Michael J. Lodes
Patricia D. Mcneill
Steven G Reed
Heather Secrist
Paul R Sleath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/569,098 external-priority patent/US6569433B1/en
Priority claimed from US09/737,178 external-priority patent/US20010029295A1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AU2001261416A1 publication Critical patent/AU2001261416A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
AU2001261416A 2000-05-10 2001-05-09 Compounds and methods for the diagnosis and treatment of babesia microti infection Abandoned AU2001261416A1 (en)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US09/569,098 US6569433B1 (en) 1996-10-01 2000-05-10 Compounds and methods for the diagnosis and treatment of B. microti infection
US09/569,098 2000-05-10
US60572400A 2000-06-27 2000-06-27
US09/605,724 2000-06-27
US65668800A 2000-09-07 2000-09-07
US09/656,688 2000-09-07
US68543600A 2000-10-10 2000-10-10
US09/685,436 2000-10-10
US09/737,178 2000-12-13
US09/737,178 US20010029295A1 (en) 1996-10-01 2000-12-13 Compounds and methods for the diagnosis and treatment of B. microti infection
US79476401A 2001-02-26 2001-02-26
US09/794,764 2001-02-26
PCT/US2001/015192 WO2001085947A2 (en) 2000-05-10 2001-05-09 Compounds and methods for the diagnosis and treatment of babesia microti infection

Publications (1)

Publication Number Publication Date
AU2001261416A1 true AU2001261416A1 (en) 2001-11-20

Family

ID=27560142

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001261416A Abandoned AU2001261416A1 (en) 2000-05-10 2001-05-09 Compounds and methods for the diagnosis and treatment of babesia microti infection

Country Status (3)

Country Link
EP (1) EP1285068A2 (en)
AU (1) AU2001261416A1 (en)
WO (1) WO2001085947A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8283124B2 (en) * 2007-10-25 2012-10-09 Abbott Laboratories Compositions for detecting antibodies to Babesia microti and methods of uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306396B1 (en) * 1996-10-01 2001-10-23 Corixa Corporation Compounds and methods for the diagnosis and treatment of B. microti infection
US6214971B1 (en) * 1996-10-01 2001-04-10 Corixa Corporation Compounds and methods for the diagnosis and treatment of Babesia microti infection
US6451315B1 (en) * 1996-10-01 2002-09-17 Corixa Corporation Compounds and methods for the diagnosis and treatment of B. microti infection

Also Published As

Publication number Publication date
EP1285068A2 (en) 2003-02-26
WO2001085947A2 (en) 2001-11-15
WO2001085947A3 (en) 2002-12-05

Similar Documents

Publication Publication Date Title
AU2001280702A1 (en) Compounds and methods for treatment and diagnosis of chlamydial infection
AU2001284857A1 (en) Surgical instrumentation and method for treatment of the spine
HUP0400477A3 (en) Compounds and methods for treatment and diagnosis of chlamydial infection
AU2002234021A1 (en) Method and device for the treatment of vulnerable tissue site
AU2002241520A1 (en) Blood assessment of injury
IL152553A0 (en) Compounds and methods for the treatment and prevention of bacterial infection
ZA200108215B (en) Compositions and methods for treatment of staphylococcal infection.
EP1144639A3 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
AU2001259507A1 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
AU2002220257A1 (en) Methods of treatment involving human mda-7
AU2002239485A1 (en) Methods for improved diagnosis and treatment of mycobacterial infections
AU4204700A (en) Compounds and methods for the diagnosis and treatment of (b. microti) infection
AU1820499A (en) Compounds and methods for the diagnosis and treatment of (b. microti) infection
AU2001232053A1 (en) System for the extracorporeal treatment of blood
AU2001234831A1 (en) Magnetoliposome composition for targeted treatment of biological tissue and associated methods
AU2002249891A1 (en) Compounds and methods for the diagnosis and treatment of babesia infection
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
AU2566201A (en) Compounds and methods for the treatment of pain
AU2001261416A1 (en) Compounds and methods for the diagnosis and treatment of babesia microti infection
AU2002302580A1 (en) Use of phyllanthus constituents for treating or preventing infections caused by hepatit
AU2420101A (en) Method and composition for the treatment of pain
AU2002230509A1 (en) Devices and methods for treating low blood sugar levels
AU2001282277A1 (en) Treatment of mycobacterial infection
AU2001281465A1 (en) Treatment of rosacea
AU2001292500A1 (en) 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain